ECSP013869A - Tratamiento del dolor - Google Patents

Tratamiento del dolor

Info

Publication number
ECSP013869A
ECSP013869A EC2001003869A ECSP013869A ECSP013869A EC SP013869 A ECSP013869 A EC SP013869A EC 2001003869 A EC2001003869 A EC 2001003869A EC SP013869 A ECSP013869 A EC SP013869A EC SP013869 A ECSP013869 A EC SP013869A
Authority
EC
Ecuador
Prior art keywords
pain treatment
buspirone
morphine
pain
action
Prior art date
Application number
EC2001003869A
Other languages
English (en)
Inventor
Francoise Camborde
Alix Cloarec
Charles Conway
Original Assignee
Union Pharma Scient Appl
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Union Pharma Scient Appl, Bristol Myers Squibb Co filed Critical Union Pharma Scient Appl
Publication of ECSP013869A publication Critical patent/ECSP013869A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Un método de tratamiento del dolor con acetaminofeno incluye la administración simultánea de buspirona. Esta combinación de sustancias produce, sorprendentemente, una respuesta analgésica del tipo de la morfina caracterízada para un rápido inicio, mayor alivio del dolor, y una mayor duración del efecto.
EC2001003869A 1999-06-30 2001-01-04 Tratamiento del dolor ECSP013869A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9908363A FR2795645B1 (fr) 1999-06-30 1999-06-30 Nouvelle association pharmaceutique a activite analgesique

Publications (1)

Publication Number Publication Date
ECSP013869A true ECSP013869A (es) 2002-09-27

Family

ID=9547486

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2001003869A ECSP013869A (es) 1999-06-30 2001-01-04 Tratamiento del dolor

Country Status (14)

Country Link
US (1) US6511982B2 (es)
EP (1) EP1189617B1 (es)
JP (1) JP2003503459A (es)
AT (1) ATE247965T1 (es)
AU (1) AU780341B2 (es)
CA (1) CA2373877A1 (es)
DE (1) DE60004833T2 (es)
EC (1) ECSP013869A (es)
ES (1) ES2204663T3 (es)
FR (1) FR2795645B1 (es)
HK (1) HK1046847B (es)
MX (1) MXPA01013403A (es)
TW (1) TW577741B (es)
WO (1) WO2001001989A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6593331B2 (en) 2001-04-17 2003-07-15 Laboratories Upsa Method for treatment of pain
JP2009504785A (ja) * 2005-08-19 2009-02-05 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 鎮痛剤としてのｓＥＨ阻害剤の使用
US20070254960A1 (en) * 2006-04-28 2007-11-01 Gruenenthal Gmbh Pharmaceutical combination
US20120148547A1 (en) * 2009-09-01 2012-06-14 Hadasit Medical Reasearch Services & Development Ltd. Combination of vitamin e and beta-glycosphingolipids in compositions and methods for preventing and treating hepatic disorders
EP3086793B1 (en) 2013-12-24 2022-05-11 Virginia Commonwealth University Use of oxygenated cholesterol sulfates (ocs) for the treatment of kidney dysfunction
WO2016133788A1 (en) 2015-02-20 2016-08-25 The Regents Of The University Of California Methods of inhibiting pain

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4182763A (en) 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
IN158970B (es) * 1981-06-09 1987-02-28 Ici Plc
DE3377796D1 (en) * 1982-05-04 1988-09-29 Ici Plc Quinoline derivatives
US4794112A (en) 1982-12-09 1988-12-27 Cooper Stephen A Acetaminophen/hydroxyzine analgesic combinations
GB8308601D0 (en) * 1983-03-29 1983-05-05 Ici Plc Heterocyclic compounds
GB2222768B (en) 1988-06-17 1992-01-22 Nat Res Dev Analgesic compounds and compositions
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
GB9601724D0 (en) * 1996-01-29 1996-03-27 Merck Sharp & Dohme Therapeutic agents
US5872145A (en) 1996-08-16 1999-02-16 Pozen, Inc. Formulation of 5-HT agonist and NSAID for treatment of migraine
JPH10194996A (ja) * 1996-12-25 1998-07-28 Janssen Pharmaceut Nv アシル化シクロデキストリン含有製薬組成物

Also Published As

Publication number Publication date
ES2204663T3 (es) 2004-05-01
FR2795645A1 (fr) 2001-01-05
DE60004833T2 (de) 2004-08-12
EP1189617B1 (fr) 2003-08-27
TW577741B (en) 2004-03-01
HK1046847B (zh) 2004-11-26
WO2001001989A1 (fr) 2001-01-11
US6511982B2 (en) 2003-01-28
AU6288500A (en) 2001-01-22
AU780341B2 (en) 2005-03-17
DE60004833D1 (de) 2003-10-02
CA2373877A1 (fr) 2001-01-11
MXPA01013403A (es) 2002-12-05
FR2795645B1 (fr) 2001-09-21
EP1189617A1 (fr) 2002-03-27
HK1046847A1 (en) 2003-01-30
US20010016584A1 (en) 2001-08-23
ATE247965T1 (de) 2003-09-15
JP2003503459A (ja) 2003-01-28

Similar Documents

Publication Publication Date Title
DK1373215T3 (da) Gelanamycinderivater egnet til behandling af cancer
DK1530469T3 (da) Transdermal dosisform omfattende et aktivt middel og et salt og fri baseform af en antagonist
TR200200118T2 (tr) Yeni bileşimler
NO924619L (no) (+)-alfa-(2,3-dimetoksyfenyl)-1-(2-(4-fluorfenyl)ethyl)-4-piperidinmetanol
ITRM20010090A0 (it) Dispositivo e metodo per guidare e limitare l'accesso di aghi ipodermici al setto di un dispositivo impiantabile in esseri umani per trattam
EA200101089A1 (ru) Новый способ лечения
BG106461A (en) Methods and use of rapid onset of reactive serotonin inhibitors for treating sexual dysfunction
ECSP045153A (es) Metodo y composición para aumentar la potencia de un analgésico de narcotico.
IS6105A (is) Aðferð til meðferðar á netjuhersli með notkun mótlyfs við integríninu alfa-4
ECSP013869A (es) Tratamiento del dolor
EA199800866A1 (ru) Способ снятия боли
PT1237562E (pt) Processo de preparacao de extractos de micania contendo micanolida e di-hidromicanolida e utilizacao no tratamento das doencas proliferativas
DK0799618T3 (da) Anvendelse af alpha1-adrenoreceptor-antagonister i fremstillingen af et medikament til forebyggelsen og behandlingen af cancer
DK0871446T3 (da) Anvendelse af eliprodil til fremstilling af et lægemiddel til behandling af ischaemiske sygdomme i nethinden eller den optiske nerve
DK1244438T3 (da) Anvendelse af beta-adrenoceptorantagonister til fremstilling af et medikament til behandling af sygdomme i den ydre nethinde
ATE302008T1 (de) Behandlung von entzündlichen erkrankungen
UY26519A1 (es) " tratamiento del dolor".
ATE291425T1 (de) R-eliprodil zur behandlung von glaucoma
DE60037402D1 (de) Behandlung von autoimmunkrankheiten mit einem extrakt von amerikanischem ginseng
IT1318090B1 (it) Procedimento e dispositivo per trattare minuteria con un agente ditrattamento liquido.
PT1150981E (pt) Composto nucleosidico terapeutico
CO5170459A1 (es) Terapia transdermica con agonistas-antagonistas de estrogenos len-ol, administrados mediante medios transdermicos
EE200100122A (et) R-(+)-alfa-(2,3-dimetoksüfenüül)-1-[2-(4-fluorofenüül)etüül]-4-piperidiinmetanooli kasutamine unehäirete raviks
UA36261A (uk) Спосіб лікування простої шизофренії з суїцидальною поведінкою
EA200000514A1 (ru) Способ лечения эректильной дисфункции